
Explore a significant study on treatment-resistant major depressive disorder in this episode. We examine the potential benefits of esketamine nasal spray versus extended-release quetiapine, both used in combination with an SSRI or SNRI. The findings could change the future approach to treating this prevalent condition. Original article here.
ABOUT THE STATE OF HEALTH
The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit stateofhealth.care
FOLLOW US